Bml Capital Management, LLC An2 Therapeutics, Inc. Put Options Transaction History
Bml Capital Management, LLC
- $161 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ANTX
# of Institutions
38Shares Held
13.8MCall Options Held
0Put Options Held
0-
Almitas Capital LLC Santa Monica, CA1.31MShares$1.51 Million0.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$1.19 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny580KShares$666,7380.0% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY579KShares$665,6480.79% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny528KShares$607,5450.0% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $22.3M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...